KHYATI PATEL: Open Payments
NPI 1891402012 · SCHAUMBURG, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$586 in 31 payments from 12 companies in 2025. Trend: 2023 $352 · 2024 $461 · 2025 $586
Food & beverage: $586
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $109 |
| ABBVIE INC. | 5 | $93 |
| Janssen Pharmaceuticals, Inc | 2 | $56 |
| Axsome Therapeutics, Inc. | 3 | $56 |
| Tris Pharma Inc | 3 | $51 |
| Alkermes, Inc. | 3 | $46 |
| Teva Pharmaceuticals USA, Inc. | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Corium, LLC | 1 | $22 |
Products named: CAPLYTA, VRAYLAR, REXULTI, SPRAVATO, Auvelity, COBENFY, Dyanavel XR, ARISTADA.
Industry payments across IL — which companies pay providers there.
